Uri Amit, MD

While transrectal ultrasound (TRUS) is the primary modality for guidance and planning in high-dose-rate prostate brachytherapy (HDR-BT), magnetic resonance imaging (MRI) is required for identifying and targeting the dominant intraprostatic lesion (DIL). The p...